Skip to main content
LFWD
NASDAQ Industrial Applications And Services

Lifeward CEO Mark Grant Departs; Josh Hexter Named Interim CEO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$7.65
Mkt Cap
$21.665M
52W Low
$4.14
52W High
$10.56
52W Position info
85% above low
Off High info
28% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

LFWD sits 85% above its 52-week low of $4.14.

Summary

Lifeward announced the departure of CEO Mark Grant and the appointment of Josh Hexter as interim CEO, along with a new CFO, Rami Aviram, effective November 1, 2026.


Key Events · Executive and Board Changes · LFWD

  • CEO Mark Grant Departs

    President and CEO Mark Grant left the company effective August 31, 2026, under a separation agreement with no cash severance; he will serve as a senior advisor through September 30, 2026 for a $40,000 consulting fee.

  • Interim CEO Appointed

    Josh Hexter, COO and Business Officer of controlling shareholder Oramed Pharmaceuticals, was named interim CEO effective September 1, 2026, with a monthly salary of NIS 100,000 plus a NIS 5,000 commuting allowance.

  • New CFO Named

    Rami Aviram was appointed CFO effective November 1, 2026, succeeding Almog Adar, whose departure was previously announced; Aviram will receive a monthly salary of NIS 70,000 plus a NIS 5,000 commuting allowance.

  • Leadership Overhaul Continues

    This filing follows the August 14, 2026 resignation of three board members and the CFO, and the August 20, 2026 appointment of three new directors, indicating a broad restructuring of management and governance.


Analysis · LFWD · Industrial Applications And Services

Lifeward's CEO Mark Grant is out effective August 31, 2026, replaced on an interim basis by Josh Hexter, a senior executive at controlling shareholder Oramed Pharmaceuticals. The company also named Rami Aviram as CFO effective November 1, 2026, filling a vacancy created by the previously announced departure of Almog Adar. The leadership overhaul comes just weeks after three board members resigned and a going concern warning was reaffirmed, underscoring the urgency of stabilizing operations.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LFWD was trading at $7.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $21.7M. The 52-week trading range was $4.14 to $10.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFWD - Latest Insights

LFWD
Nov 13, 2026, 9:22 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.42
Real-time Price: $5.42 info
Change: $0 (0%) info
Market Cap: $11.526M info
LFWD
Nov 13, 2026, 9:17 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.72
Real-time Price: $5.42 info
Change: -$0.300 (-5%) info
Market Cap: $11.526M info
LFWD
Nov 05, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $5.42 info
Change: -$0.320 (-6%) info
Market Cap: $11.526M info
LFWD
Oct 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.43
Real-time Price: $5.42 info
Change: -$1.01 (-16%) info
Market Cap: $11.526M info
LFWD
Sep 25, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.99
Real-time Price: $5.42 info
Change: -$1.57 (-22%) info
Market Cap: $11.526M info